Cargando…

New treatments for HCV: Perspective from Asia

Detalles Bibliográficos
Autores principales:	Yu, Ming‐Lung, Chuang, Wan‐Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6490446/ https://www.ncbi.nlm.nih.gov/pubmed/31312438 http://dx.doi.org/10.1002/cld.442

Ejemplares similares

Host factors determining the efficacy of hepatitis C treatment
por: Chuang, Wan-Long, et al.
Publicado: (2012)

Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies
por: Saeed, Naba, et al.
Publicado: (2016)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives
por: Maffei, Laura, et al.
Publicado: (2020)

Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region
por: Li, Philip Kam Tao, et al.
Publicado: (2021)

Molecular basis of sex differences in cancer: Perspective from Asia
por: Ornos, Eric David, et al.
Publicado: (2023)

The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
por: Huang, Ying-Chou, et al.
Publicado: (2021)

Fragility Fracture Systems: International Perspectives - Asia & Australia
por: Tarrant, Seth M., et al.
Publicado: (2022)

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy
por: Huang, Chung-Feng, et al.
Publicado: (2016)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)
por: Huang, Jee-Fu, et al.
Publicado: (2021)

The role of HCV proteins on treatment outcomes
por: Kumthip, Kattareeya, et al.
Publicado: (2015)

New Insights in Recurrent HCV Infection after Liver Transplantation
por: Hsu, Shih-Hsien, et al.
Publicado: (2013)

A New Perspective on Dry Eye Classification: Proposal by the Asia Dry Eye Society
por: Tsubota, Kazuo, et al.
Publicado: (2020)

A current perspective on antimicrobial resistance in Southeast Asia
por: Zellweger, Raphaël M, et al.
Publicado: (2017)

COVID-19 in Southeast Asia: current status and perspectives
por: Chu, Dinh-Toi, et al.
Publicado: (2022)

Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis
por: Irekeola, Ahmad Adebayo, et al.
Publicado: (2021)

Patient centred care in diabetology: an Islamic perspective from South Asia
por: Niazi, Asfandyar K, et al.
Publicado: (2012)

Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations
por: Sun, Hsin-Yun, et al.
Publicado: (2022)

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
por: Medvedev, Regina, et al.
Publicado: (2016)

New therapeutic options for HCV in Central Europe
por: Flisiak, Robert, et al.
Publicado: (2016)

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
por: Zhu, Ran Xu, et al.
Publicado: (2016)

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry
por: Chang, Te-Sheng, et al.
Publicado: (2023)

Treatment of Chronic HCV Infection in Special Populations
por: Hoefs, John, et al.
Publicado: (2006)

Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives
por: Omar, Hanan Hassan
Publicado: (2019)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
por: Thong, Bernard Yu-Hor
Publicado: (2013)

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes
por: Huang, Ching-I, et al.
Publicado: (2018)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
por: Numasawa, Yohei, et al.
Publicado: (2020)

Perspective on Particulate Matter: From Biomass Burning to the Health Crisis in Mainland Southeast Asia
por: Amnuaylojaroen, Teerachai, et al.
Publicado: (2023)

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
por: Huang, Chung-Feng, et al.
Publicado: (2021)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019)

Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia
por: Kazatchkine, Michel
Publicado: (2014)

LncRNAs in HCV Infection and HCV-Related Liver Disease
por: Unfried, Juan P., et al.
Publicado: (2020)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

New insights into HCV-related rheumatologic disorders: A review
por: Cacoub, Patrice, et al.
Publicado: (2017)

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
por: Luxenburger, Hendrik, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5h88g6buvneetqopldn71rkjus